Justin Zelin
Stock Analyst at BTIG
(1.65)
# 3,450
Out of 5,124 analysts
45
Total ratings
27.91%
Success rate
-7.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Initiates: Buy | $45 | $20.12 | +123.66% | 1 | Dec 10, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $56 | $21.01 | +166.54% | 5 | Dec 9, 2025 | |
| MRSN Mersana Therapeutics | Downgrades: Neutral | n/a | $28.93 | - | 1 | Nov 13, 2025 | |
| AAPG Ascentage Pharma Group International | Initiates: Buy | $50 | $26.24 | +90.55% | 1 | Nov 10, 2025 | |
| TCRX TScan Therapeutics | Downgrades: Neutral | n/a | $1.00 | - | 2 | Nov 4, 2025 | |
| IPHA Innate Pharma | Reiterates: Buy | $8 | $1.78 | +349.44% | 1 | Oct 29, 2025 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $62 | $34.57 | +79.35% | 3 | Oct 21, 2025 | |
| CAN Canaan | Reiterates: Buy | $8 | $0.69 | +1,059.42% | 1 | Oct 14, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $125 | $35.18 | +255.32% | 5 | Sep 22, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Buy | $20 → $7 | $1.83 | +282.51% | 3 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $7.72 | +159.07% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.98 | +203.03% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $15.40 | +172.73% | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.08 | - | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $0.98 | +81,449.44% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $91 | $34.60 | +163.01% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $160 | $8.42 | +1,800.24% | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $2.24 | +614.29% | 1 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $21.74 | +313.98% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $31 | $10.39 | +198.36% | 1 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $16 | $50.88 | -69.54% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $10 | $0.85 | +1,076.47% | 3 | Nov 16, 2022 |
ArriVent BioPharma
Dec 10, 2025
Initiates: Buy
Price Target: $45
Current: $20.12
Upside: +123.66%
Syndax Pharmaceuticals
Dec 9, 2025
Reiterates: Buy
Price Target: $56
Current: $21.01
Upside: +166.54%
Mersana Therapeutics
Nov 13, 2025
Downgrades: Neutral
Price Target: n/a
Current: $28.93
Upside: -
Ascentage Pharma Group International
Nov 10, 2025
Initiates: Buy
Price Target: $50
Current: $26.24
Upside: +90.55%
TScan Therapeutics
Nov 4, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.00
Upside: -
Innate Pharma
Oct 29, 2025
Reiterates: Buy
Price Target: $8
Current: $1.78
Upside: +349.44%
IDEAYA Biosciences
Oct 21, 2025
Reiterates: Buy
Price Target: $62
Current: $34.57
Upside: +79.35%
Canaan
Oct 14, 2025
Reiterates: Buy
Price Target: $8
Current: $0.69
Upside: +1,059.42%
Viking Therapeutics
Sep 22, 2025
Reiterates: Buy
Price Target: $125
Current: $35.18
Upside: +255.32%
Jasper Therapeutics
Sep 22, 2025
Maintains: Buy
Price Target: $20 → $7
Current: $1.83
Upside: +282.51%
Sep 9, 2025
Reiterates: Buy
Price Target: $20
Current: $7.72
Upside: +159.07%
Jan 10, 2025
Initiates: Buy
Price Target: $6
Current: $1.98
Upside: +203.03%
Dec 13, 2024
Initiates: Buy
Price Target: $42
Current: $15.40
Upside: +172.73%
May 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.08
Upside: -
Aug 15, 2023
Maintains: Buy
Price Target: $1,000 → $800
Current: $0.98
Upside: +81,449.44%
Aug 11, 2023
Maintains: Buy
Price Target: $85 → $91
Current: $34.60
Upside: +163.01%
Aug 10, 2023
Maintains: Buy
Price Target: $320 → $160
Current: $8.42
Upside: +1,800.24%
Jul 25, 2023
Initiates: Buy
Price Target: $16
Current: $2.24
Upside: +614.29%
Jun 13, 2023
Maintains: Buy
Price Target: $85 → $90
Current: $21.74
Upside: +313.98%
May 17, 2023
Initiates: Buy
Price Target: $31
Current: $10.39
Upside: +198.36%
Mar 28, 2023
Maintains: Buy
Price Target: $10 → $16
Current: $50.88
Upside: -69.54%
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $10
Current: $0.85
Upside: +1,076.47%